Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
cardiovascular disease
MedTech
J&J’s Impella pumps miss the mark in 2 major PCI studies
Two separate randomized trials failed to illustrate Impella's benefits in specific cases of patients with blocked coronary arteries.
Conor Hale
Mar 30, 2026 3:20pm
Merck dives into data showing PCSK9 pill easily outswims rivals
Mar 30, 2026 11:45am
Philips AI cath lab copilot nets FDA clearance
Mar 26, 2026 10:45am
Medtronic, Biotronik make strides in conduction system pacing
Mar 24, 2026 11:20am
XCath completes remote-controlled robotic stroke procedure
Mar 19, 2026 8:00am
JenaValve secures FDA's 1st approval in aortic regurgitation
Mar 18, 2026 10:05am
